BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

  April 28, 2026

   · 

  3 min read
• Press Releases

  AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid

  April 28, 2026

   · 

  6 min read
• Press Releases

  Sail Biomedicines to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026

  April 28, 2026

   · 

  2 min read
• Press Releases

  Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at ASGCT 2026

  April 28, 2026

   · 

  4 min read
• Press Releases

  Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium

  April 28, 2026

   · 

  3 min read
• Press Releases

  Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026

  April 28, 2026

   · 

  3 min read
• Press Releases

  Dispatch Bio Presents SEND T Cell Armoring Strategy at ASGCT 2026 Annual Meeting

  April 28, 2026

   · 

  3 min read
• Press Releases

  Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

  April 28, 2026

   · 

  6 min read
• Press Releases

  Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

  April 28, 2026

   · 

  7 min read
• Press Releases

  Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

  April 28, 2026

   · 

  8 min read